Raajit Rampal, MD, PhD, is a Hematological Oncologist at the Memorial Sloan Kettering Cancer Canter, New York, KY, specializing in myeloproliferative neoplasms (MPNs) and leukemia. Dr Rampal began his medical career at Stony Brook University, Stony Brook, NY, where he earned his MD and PhD in molecular and cellular biology. He went on to complete residency training at the University of Chicago Hospitals, Chicago, IL, and a fellowship at Weill Cornell Medical College, New York, NY, before specializing in hematological oncology at Memorial Sloan Kettering.
Speaking on translating genomic discoveries into targeted treatments in MPNs and leukemia
As a physician and active researcher, Dr Rampal’s expertise lies in the treatment of MPNs and leukemia. He is dedicated to creating novel targeted agents and conducts research into genetic events driving disease development and progression to achieve this. Dr Rampal also conducts preclinical therapeutic modelling and runs early phase investigational clinical trials.